News Sentiment

ENOV sentiment intelligence

Enovis Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 62 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 25.75 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+14.4% over one week, +18.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Enovis Corp (ENOV) Shares Surge 3.8% -- What GF Score of 60 Tells Investors

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction 14.4% Price confirming higher
Trend fit Trend inactive 18.1% over four weeks
Fair value -36.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 20
Neutral 37
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 10
Sector context 0

Sources

Coverage mix

Publishers
Market source 18
Stock Titan 6
TradingView 5
Investing.com 4
Simply Wall Street 4
StockStory 4
GlobeNewswire 2
Moomoo 2

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 18
Analyst action 6
Deals and strategy 1
Regulatory and legal 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 62
GlobeNewswire Direct company coverage

Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care

Enovis's Companion Animal Health business has launched CT-RevitL™, a new veterinary laser therapy system, in the U.S. This next-generation system aims to deliver deeper, faster, and more consistent therapeutic outcomes for animals, built on extensive research in photobiomodulatio

Tone
Positive 74/100
Event
Market update
Published
13 Jul 2026 16:11
Source
GlobeNewswire
Vet Candy Direct company coverage

Enovis Launches New Veterinary Laser Therapy System in the U.S.

Enovis Corporation has launched CT-RevitL™, a new veterinary PBM laser therapy system in the U.S., through its Companion Animal Health business. This system aims to provide enhanced clinical performance, greater mobility, and a more intuitive treatment experience for veterinary t

Tone
Positive 74/100
Event
Market update
Published
13 Jul 2026 13:42
Source
Vet Candy
Investing.com Direct company coverage

Enovis launches veterinary laser therapy system in U.S.

Enovis Corporation launched CT-RevitL, a new veterinary laser therapy system, in the U.S. This system uses photobiomodulation to manage pain, accelerate healing, and reduce inflammation in animals. The launch includes a clinical education program, and the company plans for intern

Tone
Positive 74/100
Event
Market update
Published
13 Jul 2026 13:40
Source
Investing.com
Stock Titan Direct company coverage

New CT-RevitL laser aims to speed pain relief and healing for pets

Enovis' Companion Animal Health has launched CT-RevitL, a new veterinary photobiomodulation (PBM) laser therapy system in the U.S. This system is designed to provide deeper, faster, and more consistent therapeutic outcomes for animals, leveraging over 150 published PBM studies an

Tone
Positive 73/100
Event
Market update
Published
13 Jul 2026 12:40
Source
Stock Titan
Simply Wall Street Direct company coverage

Does Enovis (ENOV) Leaving Russell Defensive Indexes Signal A Deeper Shift In Its Risk Profile?

Enovis Corporation (NYSE: ENOV) was removed from the Russell 2000 Value-Defensive and Defensive Indexes on June 27, 2026, indicating a potential shift in its risk and style classification within the small-cap universe. This exclusion prompts a reevaluation of the company's invest

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 15:40
Source
Simply Wall Street
Stock Titan Direct company coverage

American Century affiliates report 10.6% holdings in Enovis (ENOV)

American Century Investment Management, Inc. and American Century Companies, Inc. have reported a 10.6% beneficial ownership stake in Enovis Corporation (ENOV) through an amended SCHEDULE 13G/A filing. Separately, American Century Capital Portfolios, Inc. holds 4.7% of Enovis com

Tone
Neutral 50/100
Event
Deals and strategy
Published
08 Jul 2026 14:39
Source
Stock Titan
Simply Wall Street Direct company coverage

Enovis (ENOV) Following CMS Reversal, Why The Valuation Story Is Back In Focus

Enovis (ENOV) has experienced a sharp stock price increase following the Centers for Medicare & Medicaid Services' reversal of planned reimbursement cuts for its noninvasive bone growth stimulators. Despite years of weak shareholder returns, this regulatory decision has put the c

Tone
Positive 72/100
Event
Regulatory and legal
Published
07 Jul 2026 23:09
Source
Simply Wall Street
The Globe and Mail Direct company coverage

Why Enovis (ENOV) Stock Is Trading Up Today

Shares of medical technology company Enovis Corporation (ENOV) surged 15% after the Centers for Medicare & Medicaid Services reversed previously announced reimbursement cuts for the company's non-invasive bone growth stimulators. This decision, coupled with broader strength in th

Tone
Positive 74/100
Event
Market update
Published
07 Jul 2026 02:20
Source
The Globe and Mail
Moomoo Direct company coverage

Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $32

Evercore has reiterated its Buy rating on Enovis Corp (ENOV.US) but has reduced the target price for the stock to $32. The revision indicates the firm's continued positive outlook on the company despite potential adjustments to its valuation.

Tone
Neutral 50/100
Event
Analyst action
Published
06 Jul 2026 15:40
Source
Moomoo
Investing.com Direct company coverage

Enovis shares jump after Medicare reverses reimbursement cuts

Enovis Corp shares rose approximately 11% following Medicare's reversal of previously announced reimbursement cuts for the company’s non-invasive bone growth stimulators. The decision by the Centers for Medicare & Medicaid Services positively impacted the company's stock. This ar

Tone
Positive 94/100
Event
Market update
Published
06 Jul 2026 15:09
Source
Investing.com
Stock Titan Direct company coverage

Enovis (ENOV) director Christine Ortiz receives 846-share stock award

Enovis (ENOV) director Christine Ortiz was granted 846 shares of common stock on June 30, 2026, as a compensation-related award with a stated price of $0.00 per share. This transaction increased her direct holdings to 25,857 shares of Enovis common stock. The Form 4 filing indica

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 01:40
Source
Stock Titan
Investing.com UK Direct company coverage

Form 4 Enovis Corp For: 1 July By Investing.com

This article from Investing.com UK is a Form 4 filing for Enovis Corp, dated July 1st. It provides a brief mention of the company (ENOV) and its stock performance (+12.28%), alongside extensive financial market data and news headlines. The content primarily focuses on market move

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 01:09
Source
Investing.com UK
Simply Wall Street Direct company coverage

How Investors Are Reacting To Enovis (ENOV) Russell 2000 Defensive Index Removal And Rebalancing

Enovis Corporation (NYSE: ENOV) was removed from the Russell 2000 Defensive and Value-Defensive Indices on June 27, 2026, which may lead to short-term trading volatility as index-tracking funds rebalance. The article notes that this removal does not change Enovis's core strategy

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 00:13
Source
Simply Wall Street
Investing.com Direct company coverage

Enovis stock hits 52-week low at 20.45 USD

Enovis Corporation's stock has fallen to a 52-week low of $20.45, representing a 37.1% decrease over the past year and placing it 44% below its 52-week high. Despite this decline, InvestingPro analysts suggest the stock is undervalued, predicting future profitability and setting

Tone
Negative 39/100
Event
Market update
Published
30 Jun 2026 15:09
Source
Investing.com
Simply Wall Street Direct company coverage

Enovis (ENOV) Could Be 46% Undervalued As Net Profit Jumps 84%

Enovis (ENOV) recently reported an 84.34% year-over-year increase in net profit on quarterly revenue of US$589.15 million, suggesting it could be significantly undervalued by 46% according to certain models, trading at US$22.71 against a fair value of US$42.30. Despite a weak yea

Tone
Positive 75/100
Event
Earnings
Published
27 Jun 2026 14:42
Source
Simply Wall Street
TradingView Direct company coverage

Enterprise value to revenue forward of Enovis Corporation – NYSE:ENOV

This article provides a brief financial snippet for Enovis Corporation (NYSE: ENOV), displaying its enterprise value to revenue forward. It indicates the period, value, and change percentages for this financial metric. The content is presented by TradingView and includes standard

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 00:10
Source
TradingView
TradingView Direct company coverage

Enovis Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh

This page provides financial actuals and estimates for Enovis Corporation (E2NO34) on the BMFBOVESPA exchange. It allows users to explore reported financial data and analyst estimates across various financial statements and valuation metrics. Users can compare actual results with

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 16:09
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Enovis Corporation – NYSE:ENOV

The article focuses on the enterprise value to EBITDA forward for Enovis Corporation (NYSE: ENOV). It appears to be a financial data snippet from TradingView, providing a period, value, and change for this specific financial metric. The content is presented within the context of

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 13:09
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Enovis Corporation – NYSE:ENOV

The article displays the "Price to earnings forward" metric for Enovis Corporation (NYSE: ENOV). It shows that for the displayed period, the value was 'No trades', indicating no recent trading activity for this specific financial metric. The content is primarily a data point pres

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 03:41
Source
TradingView
TradingView Direct company coverage

Enovis Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh Actuals & Estimates (BMFBOVESPA:E2NO34)

This article provides an overview of Enovis Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh (E2NO34) on the BMFBOVESPA exchange, focusing on its financial actuals and estimates. It highlights that users can explore reported financial data and analyst estimat

Tone
Neutral 50/100
Event
Analyst action
Published
26 Jun 2026 00:41
Source
TradingView
Finviz Direct company coverage

ENOV - Enovis Corp Short Interest

This article provides a detailed financial overview of Enovis Corp (ENOV), including its last closing price, market capitalization, income, sales, and various financial ratios. It also highlights short interest data, insider and institutional ownership, and stock performance over

Tone
Negative 37/100
Event
Market update
Published
25 Jun 2026 11:10
Source
Finviz
TradingKey Direct company coverage

Enovis Corp (ENOV) Financial Health: Profitability & Balance Sheet Analysis

Enovis Corp (ENOV) has a current financial score of 6.28, placing it 164th out of 204 in the Healthcare Equipment & Supplies industry, indicating weak financial status but average operating efficiency. The company recently reported a quarterly revenue of $589.15M, a 5.43% year-ov

Tone
Positive 61/100
Event
Earnings
Published
24 Jun 2026 09:11
Source
TradingKey
TradingKey Direct company coverage

Enovis Corp (ENOV) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Enovis Corp (ENOV), detailing its current price momentum score, support and resistance levels. It reviews various technical indicators like MACD, RSI, and moving averages, all of which currently suggest a "Sell" signal for the stock.

Tone
Negative 34/100
Event
Market update
Published
24 Jun 2026 05:09
Source
TradingKey
Intellectia AI Direct company coverage

ENOV Technical Analysis & Stock Price Forecast

This article provides a technical analysis and stock price forecast for Enovis Corp (ENOV), indicating a "Strong Sell" consensus based on various technical indicators and moving averages. The analysis highlights key support and resistance levels, momentum indicators like RSI and

Tone
Negative 27/100
Event
Guidance
Published
23 Jun 2026 02:40
Source
Intellectia AI